GO:0071885 N-terminal protein N-methyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071885 defines N-terminal protein N-methyltransferase activity, which transfers a methyl group from S-adenosyl-L-methionine to the alpha-amino group of a protein's N-terminal residue.
• The term is a molecular_function in the Gene Ontology and is synonymous with X-Pro-Lys N-terminal methyltransferase activity.
• Substrate specificity often requires an N-terminal X-Pro-Lys motif, where X can be Pro, Ala, or Ser, as shown for yeast Tae1p and mammalian METTL11A.
• N-terminal methylation can influence protein stability, interactions, and subcellular localization, with downstream effects on chromatin regulation and cancer biology.
• Dysregulation of N-terminal methyltransferases and related methyltransferases has been linked to cancer, neurodevelopmental disorders, and metabolic diseases.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models are essential to dissect the causal roles of these enzymes in physiology and disease.
Description
N-terminal protein N-methyltransferase activity (GO:0071885) is a molecular function that catalyzes the transfer of a methyl group from S-adenosyl-L-methionine (AdoMet) to the alpha-amino group of the N-terminal amino or imino acid residue of a protein substrate. This modification is distinct from lysine and arginine methylation because it targets the free alpha-amino group at the very start of a polypeptide chain. The best-characterized enzymes with this activity include yeast Tae1p and its mammalian homolog METTL11A (also known as NRMT1), which preferentially modify substrates bearing an N-terminal X-Pro-Lys sequence, where X can be Pro, Ala, or Ser. Researchers study this term because N-terminal methylation can alter protein-protein interactions, stability, and chromatin association, thereby influencing gene expression and cellular phenotypes. For example, enhanced methyltransferase activity of SMYD3 after cleavage of its N-terminal region has been observed in human cancer cells, highlighting how N-terminal processing can modulate enzyme function. Similarly, acetylation of the N-terminal valine of glycine N-methyltransferase affects enzyme inhibition by folate, illustrating crosstalk between N-terminal modifications and metabolic regulation. Understanding GO:0071885 is therefore critical for interpreting how cells use methylation to control protein function at the post-translational level.
N-terminal protein N-methyltransferase activity At A Glance
| GO ID | GO:0071885 |
|---|---|
| GO term | N-terminal protein N-methyltransferase activity |
| Ontology | molecular_function |
| Synonym | X-Pro-Lys N-terminal methyltransferase |
| Definition | Catalysis of the transfer of a methyl group from S-adenosyl-L-methionine (AdoMet) to the alpha-amino group of the N-terminal amino or imino acid residue of a protein substrate. |
| Major function | Post-translational methylation of protein N-termini, often at X-Pro-Lys motifs. |
| Example enzymes | Yeast Tae1p and mammalian METTL11A (NRMT1). |
| Substrate motif | Preferential modification of N-terminal sequences with X-Pro-Lys, where X can be Pro, Ala, or Ser. |
| Cofactor | S-adenosyl-L-methionine (AdoMet) as methyl donor. |
What Is GO:0071885?
In simple terms, GO:0071885 describes enzymes that attach a methyl group to the very first amino acid of a protein. These enzymes use S-adenosyl-L-methionine as the methyl donor and modify the alpha-amino group of the N-terminal residue, often when the protein starts with a specific sequence such as X-Pro-Lys. This activity is a molecular function, meaning it describes what the enzyme does at the biochemical level rather than a whole pathway or cellular location.
Why Is N-terminal protein N-methyltransferase activity Important in Cell Biology?
GO:0071885 is important because N-terminal methylation is a conserved post-translational modification that can regulate protein function, stability, and interactions, thereby impacting diverse cellular processes such as chromatin regulation, transcription, and metabolism. Dysregulation of N-terminal methyltransferases and related methyltransferase activities has been implicated in cancer, neurodevelopmental disorders, and metabolic diseases, making this term a focal point for both basic and translational research.
• N-terminal methylation can affect protein stability and half-life, influencing steady-state protein levels.
• The modification can modulate protein-protein interactions, including those involved in chromatin remodeling.
• Enzymes with this activity, such as METTL11A, are conserved from yeast to humans, underscoring their fundamental biological roles.
• Altered N-terminal methylation may contribute to cancer progression, as suggested by studies on SMYD3 in human cancer cells.
• N-terminal processing of methyltransferases like glycine N-methyltransferase can affect folate sensitivity and metabolic regulation.
• Dysregulation of methyltransferase complexes, including COMPASS and PRMT5, has been linked to developmental disorders and cancer.
• Understanding GO:0071885 aids in interpreting genotype-phenotype associations in Kleefstra syndrome and related neurodevelopmental conditions.
• The activity is a potential therapeutic target because small-molecule inhibitors could modulate N-terminal methylation in disease contexts.
• CRISPR-based models enable precise dissection of the causal roles of N-terminal methyltransferases in vivo.
• Bioinformatics and proteomics approaches can identify novel substrates and regulatory networks for this activity.
What Happens During N-terminal protein N-methyltransferase activity?
Substrate recognition and binding
In simple terms: The enzyme first grabs the target protein by its starting end.
N-terminal methyltransferases recognize specific N-terminal sequences, often X-Pro-Lys, where X can be Pro, Ala, or Ser, as demonstrated for yeast Tae1p and mammalian METTL11A. This recognition ensures that only proteins with the appropriate N-terminal motif are modified, providing substrate specificity.
Methyl group transfer from AdoMet
In simple terms: The enzyme takes a methyl group from a donor molecule and attaches it to the protein's first amino acid.
The catalytic step involves the transfer of a methyl group from S-adenosyl-L-methionine (AdoMet) to the alpha-amino group of the N-terminal residue of the substrate protein. This reaction converts AdoMet to S-adenosylhomocysteine and results in a mono-, di-, or tri-methylated N-terminus depending on the enzyme and substrate.
Conformational changes and product release
In simple terms: After the methyl group is added, the enzyme lets go of the modified protein.
Following methyl transfer, the enzyme undergoes conformational changes that facilitate product release, allowing it to catalyze subsequent rounds of modification. The modified N-terminus can then engage in new interactions or alter the protein's stability and localization.
Integration with other post-translational modifications
In simple terms: N-terminal methylation does not happen in isolation; it can work together with other modifications.
N-terminal methylation can crosstalk with other modifications such as acetylation, as seen for glycine N-methyltransferase where acetylation of the N-terminal valine affects folate inhibition. This integration fine-tunes protein function in response to cellular signals.
Key Genes Involved in GO:0071885 N-terminal protein N-methyltransferase activity
The following genes and proteins are experimentally linked to N-terminal protein N-methyltransferase activity or related methyltransferase functions.
| Gene | Major Role | Research Relevance |
|---|---|---|
| METTL11A (NRMT1) | Catalyzes N-terminal methylation of proteins with X-Pro-Lys motifs | Key enzyme for GO:0071885; studied in chromatin regulation and cancer |
| TAE1 (yeast) | Yeast N-terminal methyltransferase that modifies X-Pro-Lys substrates | Model for understanding substrate specificity and evolution |
| SMYD3 | Histone methyltransferase with enhanced activity upon N-terminal cleavage | Linked to cancer cell proliferation; N-terminal processing affects activity |
| EHMT1 | Histone methyltransferase involved in chromatin regulation | Mutations cause Kleefstra syndrome; genotype-phenotype associations studied |
| COMPASS complex subunits | Histone H3K4 methylation machinery | Structural and functional studies reveal subunit arrangement and regulation |
| PRMT5 | Arginine methyltransferase that methylates histone H2A/H4 tails | MEP50 WD repeat protein positions tails for efficient methylation |
| Clr4/Suv39 | Histone H3K9 methyltransferase in heterochromatin | Intrinsically disordered region regulates enzymatic activity and spreading |
| NSD3 | Histone lysine methyltransferase | Isoform-specific functions in cancer; methyltransferase-dependent roles |
| GNMT | Glycine N-methyltransferase involved in folate metabolism | N-terminal acetylation affects enzyme inhibition by folate |
| H2B | Histone substrate for ubiquitination-dependent H3K4 methylation | COMPASS-mediated methylation requires H2B ubiquitination |
| H3K4 | Histone mark deposited by COMPASS | Read by effector proteins to regulate transcription |
| H3K9 | Histone mark deposited by Clr4/Suv39 | Associated with heterochromatin formation and gene silencing |
| H2A/H4 | Histone tails methylated by PRMT5 | Arginine methylation impacts chromatin structure |
| MEP50 | WD repeat protein that positions histone tails | Required for efficient PRMT5-mediated methylation |
| Suv39 | Histone methyltransferase in fission yeast | Regulates heterochromatin spreading |
| Tae1p | Yeast N-terminal methyltransferase | Prototype for X-Pro-Lys specificity |
| NRMT1 | Mammalian N-terminal methyltransferase | Ortholog of Tae1p; modifies proteins with X-Pro-Lys N-termini |
How Is N-terminal protein N-methyltransferase activity Regulated?
N-terminal protein N-methyltransferase activity is regulated at multiple levels. Enzyme abundance and activity can be controlled by proteolytic cleavage, as shown for SMYD3 where cleavage of its N-terminal region enhances methyltransferase activity in human cancer cells. Additionally, post-translational modifications such as acetylation of the N-terminal valine of glycine N-methyltransferase can alter enzyme inhibition by folate, providing a feedback mechanism. The intrinsically disordered region of Clr4/Suv39 regulates its enzymatic activity and ensures heterochromatin spreading, illustrating how protein structure modulates methyltransferase function. Furthermore, subunit arrangement and interacting proteins, such as MEP50 for PRMT5, are critical for efficient methylation of histone substrates.
N-terminal protein N-methyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SMYD3 | Cancer cell proliferation | Knockout and point-mutation models in cancer cell lines |
| EHMT1 | Kleefstra syndrome | Knock-in mouse models carrying patient variants |
| NSD3 | Cancer (isoform-specific functions) | Overexpression and knockout models in cancer cells |
| GNMT | Folate metabolism disorders | Point-mutation models to study N-terminal acetylation |
| METTL11A | Chromatin regulation and cancer | Knockout and tagged knock-in models |
Cancer
Dysregulation of N-terminal methyltransferases and related methyltransferase activities has been observed in cancer. Enhanced methyltransferase activity of SMYD3 after cleavage of its N-terminal region was detected in human cancer cells, suggesting a role in tumorigenesis. NSD3, a histone lysine methyltransferase, exhibits isoform-specific functions in cancer, with both methyltransferase-dependent and independent roles. These findings highlight the potential of targeting N-terminal methylation pathways for cancer therapy.
Neurodevelopmental disorders
Mutations in EHMT1, a histone methyltransferase, cause Kleefstra syndrome, a neurodevelopmental disorder. Comprehensive variant analysis has broadened genotype-phenotype associations and molecular mechanisms, implicating methyltransferase dysfunction in disease. Although EHMT1 is not an N-terminal methyltransferase, its study underscores the importance of methylation in neurodevelopment.
Metabolic and folate-related disorders
Glycine N-methyltransferase (GNMT) is involved in folate metabolism, and acetylation of its N-terminal valine affects enzyme inhibition by folate. This suggests that N-terminal modifications can influence metabolic pathways and may contribute to folate-related disorders.
From N-terminal protein N-methyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of METTL11A affect chromatin regulation? | Knockout cell lines and mouse models |
| How does N-terminal cleavage of SMYD3 alter its activity? | Point-mutation and knockout models in cancer cells |
| What is the role of EHMT1 variants in neurodevelopment? | Knock-in mouse models with patient-specific mutations |
| How does N-terminal acetylation of GNMT affect folate sensitivity? | Point-mutation models in hepatocytes |
| Does NSD3 overexpression drive tumor growth? | Overexpression models in cancer cell lines |
| How do COMPASS subunits assemble and function? | Tagged knock-in and knockout yeast models |
How to Study the N-terminal protein N-methyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry | N-terminal methylation sites and stoichiometry | Identification of novel substrates |
| Methyl-specific antibodies | Enrichment of methylated proteins | Western blot and immunofluorescence |
| CRISPR knockout screens | Gene essentiality and pathway dependencies | Cancer and developmental studies |
| X-ray crystallography | Three-dimensional structure of enzyme-substrate complexes | Mechanistic studies |
| Biochemical methyltransferase assays | Enzyme kinetics and cofactor usage | Inhibitor screening |
| RNA-seq | Transcriptional changes | Pathway analysis |
| ChIP-seq | Histone modification and chromatin occupancy | Epigenomic profiling |
Proteomics and methyl-specific antibodies
Mass spectrometry-based proteomics can identify N-terminally methylated proteins and map modification sites. Methyl-specific antibodies enable enrichment and detection of methylated N-termini in complex samples.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can uncover genes required for N-terminal methylation and its downstream effects. These screens help link genotype to phenotype in cancer and developmental contexts.
Structural biology and biochemistry
X-ray crystallography and cryo-EM reveal how methyltransferases recognize substrates and catalyze methyl transfer. Biochemical assays with recombinant enzymes and AdoMet measure activity and kinetics.
Transcriptomics and epigenomics
RNA-seq and ChIP-seq can assess transcriptional and chromatin changes upon modulation of N-terminal methyltransferases. These methods help define the biological impact of the modification.
How CRISPR Can Be Used to Study GO:0071885 N-terminal protein N-methyltransferase activity
Knockout
CRISPR knockout of N-terminal methyltransferase genes such as METTL11A or SMYD3 can reveal their essential roles in cell proliferation, chromatin regulation, and disease progression. Knockout models are valuable for identifying downstream targets and compensatory pathways.
Point Mutation
Introducing point mutations in catalytic residues or substrate-binding motifs of N-terminal methyltransferases can dissect their enzymatic activity from scaffolding functions. For example, point mutations in EHMT1 have been used to model Kleefstra syndrome variants.
Knock-in
Knock-in of tagged or patient-specific variants allows precise tracking of protein localization and function. Tagged knock-in models of COMPASS subunits have elucidated complex assembly and substrate recognition.
Overexpression
Overexpression of N-terminal methyltransferases like NSD3 or SMYD3 can drive oncogenic phenotypes, providing models to test inhibitors and study isoform-specific functions.
How EDITGENE Supports N-terminal protein N-methyltransferase activity Research
Researchers studying N-terminal protein N-methyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for N-terminal protein N-methyltransferase activity research.
Frequently Asked Questions About N-terminal protein N-methyltransferase activity
What is N-terminal protein N-methyltransferase activity?
It is a molecular function (GO:0071885) that transfers a methyl group from S-adenosyl-L-methionine to the alpha-amino group of a protein's N-terminal residue, often at X-Pro-Lys motifs.
What genes are involved in N-terminal protein N-methyltransferase activity?
Key genes include METTL11A (NRMT1) and yeast TAE1, which encode enzymes that catalyze this modification.
What is the synonym for GO:0071885?
The synonym is X-Pro-Lys N-terminal methyltransferase.
How does N-terminal methylation affect protein function?
It can alter protein stability, interactions, and localization, impacting processes like chromatin regulation and metabolism.
Which diseases are linked to N-terminal methyltransferases?
Dysregulation has been implicated in cancer, neurodevelopmental disorders like Kleefstra syndrome, and metabolic conditions.
What experimental models are used to study GO:0071885?
CRISPR knockout, point-mutation, knock-in, and overexpression models in cell lines and mice are commonly used.
What is the substrate motif for METTL11A?
METTL11A preferentially modifies N-terminal sequences with X-Pro-Lys, where X can be Pro, Ala, or Ser.
How is N-terminal methyltransferase activity regulated?
It can be regulated by proteolytic cleavage, post-translational modifications, and interacting proteins.
Can N-terminal methylation crosstalk with other modifications?
Yes, it can crosstalk with acetylation, as seen for glycine N-methyltransferase where N-terminal acetylation affects folate inhibition.
What methods are used to detect N-terminal methylation?
Mass spectrometry, methyl-specific antibodies, and biochemical assays are commonly employed.
Conclusion
N-terminal protein N-methyltransferase activity (GO:0071885) is a conserved post-translational modification that regulates protein function and has broad implications for chromatin biology, cancer, and neurodevelopment. Understanding its mechanisms and substrates requires integrated approaches, including CRISPR-based models, proteomics, and structural biology. EDITGENE provides end-to-end services to support researchers in dissecting this important molecular function.
References
- 1. Rots D et al.. 2024. Comprehensive EHMT1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra syndrome.. Am J Hum Genet 111(8):1605-1625 PMID: 39013458
- 2. Silva FP et al.. 2008. Enhanced methyltransferase activity of SMYD3 by the cleavage of its N-terminal region in human cancer cells.. Oncogene 27(19):2686-92 PMID: 17998933
- 3. Hsu PL et al.. 2019. Structural Basis of H2B Ubiquitination-Dependent H3K4 Methylation by COMPASS.. Mol Cell 76(5):712-723.e4 PMID: 31733991
- 4. Luka Z et al.. 2008. Acetylation of N-terminal valine of glycine N-methyltransferase affects enzyme inhibition by folate.. Biochim Biophys Acta 1784(9):1342-6 PMID: 18501206
- 5. Nakamura R et al.. 2025. Intrinsically disordered region of Clr4/Suv39 regulates its enzymatic activity and ensures heterochromatin spreading.. Nucleic Acids Res 53(17) PMID: 40923761
- 6. Burgos ES et al.. 2015. Histone H2A and H4 N-terminal tails are positioned by the MEP50 WD repeat protein for efficient methylation by the PRMT5 arginine methyltransferase.. J Biol Chem 290(15):9674-89 PMID: 25713080
- 7. Wang Y et al.. 2018. Architecture and subunit arrangement of the complete Saccharomyces cerevisiae COMPASS complex.. Sci Rep 8(1):17405 PMID: 30479350
- 8. Nuñez Y et al.. 2024. NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions.. Int J Mol Sci 25(2) PMID: 38256018
